OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Editorial Board	179
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	140
Inhaled aerosol viral-vectored vaccines against tuberculosis	116
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	82
Transmission patterns of hepatitis E virus	81
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	78
The enigmatic roles of Anelloviridae and Redondoviridae in humans	73
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	65
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	65
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	63
Future considerations for the mRNA-lipid nanoparticle vaccine platform	63
Structural basis for neutralization of enterovirus	62
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	60
Editorial Board	58
Virus–host protein interactions as footprints of human cytomegalovirus replication	53
Editorial overview: Viral pathogenesis	52
Human placental models for studying viral infections	48
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids	47
Recent progress in development of monoclonal antibodies against human cytomegalovirus	46
Editorial Board	44
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	43
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	42
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1	42
New preventive strategies for respiratory syncytial virus infection in children	42
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	40

The journey of herpesvirus capsids and genomes to the host cell nucleus	38
Emerging technologies in the study of the virome	37
Adenovirus – a blueprint for gene delivery	36
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	35
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	34
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	34
A complex immune communication between eicosanoids and pulmonary macrophages	33
Perspective on taxonomic classification of uncultivated viruses	33
Epigenetic control of the Epstein-Barr lifecycle	33
Platelets in the pathogenesis of flavivirus disease	32
Mitigation of evolved bacterial resistance to phage therapy	30
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	30
Engineering therapeutic phages for enhanced antibacterial efficacy	29
Retasking of canonical antiviral factors into proviral effectors	28
Editorial Board	28
Asymmetry in icosahedral viruses	27
When good turns bad: how viruses exploit innate immunity factors	26
Tissue-resident memory T cells in protective immunity to influenza virus	26
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	26
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	25
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	24
Modeling zoonotic and vector-borne viruses	24
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	24
Mechanisms of HCV resistance to broadly neutralizing antibodies	24
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	24
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	23
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	23
Immune responses to human respiratory coronaviruses infection in mouse models	23
The virome of vector mosquitoes	23
Oncogenic Animal Herpesviruses	23
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	22
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	22
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	22
Antigenic evolution of SARS coronavirus 2	21
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	21
The impact of high-resolution structural data on stemming the COVID-19 pandemic	21
Deimmunization of flagellin adjuvant for clinical application	21
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	20
Bat virome research: the past, the present and the future	20
Editorial overview	20
Viral Z-RNA triggers ZBP1-dependent cell death	20
Advances in human monoclonal antibody therapy for HBV infection	20
Structure and physiology of giant DNA viruses	19
Broadly neutralizing antibodies against COVID-19	19
Editorial Board	19
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	19
Editorial Board	19
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2	18
Early signaling pathways in virus-infected cells	18
Editorial overview: Viral immunology before COVID-19	18

Mapping conformational epitopes by NMR spectroscopy	18
How and why RNA genomes are (partially) ordered in viral capsids	18
Microbiota as a potentially-modifiable factor influencing COVID-19	17
Editorial overview: Special issue on phage therapy	17
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	16
Rotavirus cell entry: not so simple after all	16
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers	16
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success	15
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	15
The influence of microbiota-derived metabolites on viral infections	15
Structural insights into hepatitis C virus neutralization	15
Editorial overview: Engineering elimination of chronic viral hepatitis	15
Accumulation of host cell genetic errors following high-risk HPV infection	15
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	14
Editorial overview: Special issue on virus structure and expression in current opinion in virology	14
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	14
Fighting viruses with computers, right now	14
Proteases and variants: context matters for SARS-CoV-2 entry assays	13
Editorial overview: Virus structure and expression	13
The intestinal virome: lessons from animal models	13
Natural killer cells and unconventional T cells in COVID-19	13
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	13
Editorial Board	12
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	12
Broad neutralizing antibody-based strategies to tackle influenza	12
Assembly of the virome in newborn human infants	12
Editorial Board	12
Phage therapy for secondary bacterial infections with COVID-19	12
Lying low-chromatin insulation in persistent DNA virus infection	12
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	12
Koala retrovirus and neoplasia: correlation and underlying mechanisms	12
European regulatory aspects of phage therapy: magistral phage preparations	12
Integrative structural biology of HIV-1 capsid protein assemblies: combining experiment and computation	11
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	11
A comparative review of adenovirus A12 and C5 oncogenes	11
Virus structure and structure-based antivirals	11
The role of human lipoproteins for hepatitis C virus persistence	11
Editorial Board	11
Cryo-EM to visualize the structural organization of viruses	11
Editorial Board	11
Viral determinants influencing intra- and intercellular communication in cytomegalovirus infection	10
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	10
Zoonotic disease and virome diversity in bats	10
Editorial Board	10
Editorial Board	10
Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection	10
Animal models of SARS-CoV-2 transmission	10
Therapeutic approaches to Epstein–Barr virus cancers	10
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	10
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology	10
The long and winding road: human papillomavirus entry and subcellular trafficking	10
Endocytosis of Bacteriophages	10
An overview of the current state of phage therapy for the treatment of biofilm-related infections	10